Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.
Even
Venture Round in 2024
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.
Q Bio
Venture Round in 2024
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.
TORTUS AI
Seed Round in 2024
TORTUS AI creates and operates an online tool using artificial intelligence for the healthcare industry. It aims to eliminate human error in medicine through clinician co-working with AI. It provides an AI agent for healthcare, a digital worker that can take over all digital tasks from a clinician such as documentation, requesting tests, access and summarizing patient information. Tortus AI was founded in 2022 and is based in London, England.
Gather Health
Series A in 2023
Gather Health is an international healthcare technology company dedicated to empowering patients with chronic diseases to enhance their health. The company specializes in mobile and cloud-based healthcare applications that utilize the latest medical and behavioral change research to motivate and educate patients. By connecting physicians, patients, their families, and patient communities, Gather Health aims to provide continuous and holistic care, ultimately improving health outcomes. The rise in chronic diseases, such as obesity and diabetes, has created a demand for better care, which Gather Health addresses by equipping patients and healthcare providers with effective tools for managing these conditions. Their flagship product, the Gather Health Diabetes platform, has been successfully implemented in cities including Mumbai, Ahmedabad, Hyderabad, Chennai, and Bangalore, showing positive health outcomes for patients and increased efficiency for healthcare providers. Headquartered in Hong Kong, with offices in Beijing, New York, and India, Gather Health's team comprises clinicians, health experts, interaction designers, and engineers experienced in global healthcare.
Even
Convertible Note in 2022
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.
Loop
Series B in 2022
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.
Loop
Series A in 2021
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.
House Rx
Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
Connie Health
Series A in 2021
Connie Health is a provider of medical advisory services focused on enhancing the experience of older Americans in navigating Medicare decision-making. The company utilizes an AI-driven technology platform, complemented by local Medicare experts, to assist individuals in maximizing their insurance benefits, optimizing prescription costs, and identifying healthcare providers in their vicinity. By offering personalized support, Connie Health empowers seniors to make informed healthcare choices, select the most appropriate healthcare plans, and effectively understand the benefits of their insurance coverage.
Even
Seed Round in 2021
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.
Ellipsis Health
Series A in 2021
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing analytics solutions that utilize artificial intelligence to enhance behavioral health assessments by analyzing patient speech and clinical data. The company's platform offers a behavioral biomarker technology that generates clinical-grade evaluations of anxiety and depression severity, as well as sub-clinical assessments of stress. This innovative approach allows healthcare systems to continuously monitor their patient populations for mental health conditions, particularly depression, and facilitates timely support for patients in need. By integrating affective computing into patient and care team interactions, Ellipsis Health aims to create real-time behavioral health vital signs for improved patient outcomes.
Lumiata
Series B in 2021
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.
Oscar Health
Venture Round in 2020
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Oscar Health
Venture Round in 2020
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Siren Care
Series B in 2020
Siren Care, Inc. is a health technology company based in San Francisco, California, founded in 2015. It specializes in wearable devices designed for diabetic health tracking, particularly through its flagship product, the Siren diabetic socks. These smart socks continuously monitor foot temperature, providing crucial data that can help detect early signs of diabetic ulcers, thereby reducing the risk of amputations. The temperature data is transmitted via an application, allowing healthcare providers to monitor patients effectively and intervene early if necessary. Siren Care aims to enhance healthcare for individuals with chronic diseases by collaborating with both providers and payers to improve patient outcomes in diabetic foot care.
Q Bio
Series B in 2020
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.
Connie Health
Pre Seed Round in 2020
Connie Health is a provider of medical advisory services focused on enhancing the experience of older Americans in navigating Medicare decision-making. The company utilizes an AI-driven technology platform, complemented by local Medicare experts, to assist individuals in maximizing their insurance benefits, optimizing prescription costs, and identifying healthcare providers in their vicinity. By offering personalized support, Connie Health empowers seniors to make informed healthcare choices, select the most appropriate healthcare plans, and effectively understand the benefits of their insurance coverage.
Digi-Prex
Seed Round in 2019
Digi-Prex is a Chronic disease management platform that provides patients with a holistic solution to assist in the management of their conditions. We start by providing these patients with a subscription that allows them access to discounted medicines delivered to their home regularly and provides them access to a full service platform customized to their particular condition allowing them a one stop shop to assist in the management of their condition.
Siren Care
Series A in 2018
Siren Care, Inc. is a health technology company based in San Francisco, California, founded in 2015. It specializes in wearable devices designed for diabetic health tracking, particularly through its flagship product, the Siren diabetic socks. These smart socks continuously monitor foot temperature, providing crucial data that can help detect early signs of diabetic ulcers, thereby reducing the risk of amputations. The temperature data is transmitted via an application, allowing healthcare providers to monitor patients effectively and intervene early if necessary. Siren Care aims to enhance healthcare for individuals with chronic diseases by collaborating with both providers and payers to improve patient outcomes in diabetic foot care.
Lumiata
Series B in 2018
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.
Zebra Medical Vision
Series C in 2018
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.
Siren Care
Seed Round in 2018
Siren Care, Inc. is a health technology company based in San Francisco, California, founded in 2015. It specializes in wearable devices designed for diabetic health tracking, particularly through its flagship product, the Siren diabetic socks. These smart socks continuously monitor foot temperature, providing crucial data that can help detect early signs of diabetic ulcers, thereby reducing the risk of amputations. The temperature data is transmitted via an application, allowing healthcare providers to monitor patients effectively and intervene early if necessary. Siren Care aims to enhance healthcare for individuals with chronic diseases by collaborating with both providers and payers to improve patient outcomes in diabetic foot care.
Oscar Health
Venture Round in 2018
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Q Bio
Series A in 2018
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.
Ellipsis Health
Seed Round in 2017
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing analytics solutions that utilize artificial intelligence to enhance behavioral health assessments by analyzing patient speech and clinical data. The company's platform offers a behavioral biomarker technology that generates clinical-grade evaluations of anxiety and depression severity, as well as sub-clinical assessments of stress. This innovative approach allows healthcare systems to continuously monitor their patient populations for mental health conditions, particularly depression, and facilitates timely support for patients in need. By integrating affective computing into patient and care team interactions, Ellipsis Health aims to create real-time behavioral health vital signs for improved patient outcomes.
Lumiata
Series A in 2017
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.
Vida Health
Series B in 2016
Vida Health, Inc. is a virtual care company based in San Francisco, California, focused on addressing chronic physical and behavioral health conditions. The company offers a comprehensive digital platform that combines artificial intelligence with human support, providing users access to coaches, nutritionists, diabetes educators, nurses, trainers, and licensed therapists. This platform features personalized content, lessons, and habit recommendations, along with video sessions and messaging to facilitate communication. Vida Health's approach aims to treat the whole health of individuals by integrating mental and physical care, helping users prevent, manage, and potentially reverse chronic conditions such as diabetes and hypertension, as well as associated mental health issues like stress, depression, and anxiety. Founded in 2014, Vida Health has earned the trust of major employers and health plans in the United States for its clinically validated services.
Color
Series B in 2016
Color is a healthcare technology company that provides a comprehensive platform for managing large-scale health initiatives, including population genomics and COVID-19 testing. The company focuses on delivering equitable and accessible healthcare programs tailored for businesses, schools, and public health departments. By centralizing essential healthcare capabilities, Color addresses logistical challenges and enhances the delivery of preventive care. Its offerings facilitate a range of services, from testing and screening to treatment and referrals, thereby supporting clinical teams in effectively managing public health across diverse populations. Through its innovative model, Color aims to improve health outcomes and create sustainable revenue streams while ensuring that quality healthcare is available to all.
Lumiata
Series B in 2016
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.
Zebra Medical Vision
Series B in 2016
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.
Oscar Health
Private Equity Round in 2016
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Color
Series A in 2015
Color is a healthcare technology company that provides a comprehensive platform for managing large-scale health initiatives, including population genomics and COVID-19 testing. The company focuses on delivering equitable and accessible healthcare programs tailored for businesses, schools, and public health departments. By centralizing essential healthcare capabilities, Color addresses logistical challenges and enhances the delivery of preventive care. Its offerings facilitate a range of services, from testing and screening to treatment and referrals, thereby supporting clinical teams in effectively managing public health across diverse populations. Through its innovative model, Color aims to improve health outcomes and create sustainable revenue streams while ensuring that quality healthcare is available to all.
Oscar Health
Series C in 2015
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Zebra Medical Vision
Seed Round in 2015
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.
Vida Health
Series A in 2014
Vida Health, Inc. is a virtual care company based in San Francisco, California, focused on addressing chronic physical and behavioral health conditions. The company offers a comprehensive digital platform that combines artificial intelligence with human support, providing users access to coaches, nutritionists, diabetes educators, nurses, trainers, and licensed therapists. This platform features personalized content, lessons, and habit recommendations, along with video sessions and messaging to facilitate communication. Vida Health's approach aims to treat the whole health of individuals by integrating mental and physical care, helping users prevent, manage, and potentially reverse chronic conditions such as diabetes and hypertension, as well as associated mental health issues like stress, depression, and anxiety. Founded in 2014, Vida Health has earned the trust of major employers and health plans in the United States for its clinically validated services.
Oscar Health
Series B in 2014
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Lumiata
Series A in 2014
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.
Oscar Health
Series A in 2014
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Oscar Health
Series A in 2013
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.